Abstract
RESTORATION of allograft immunity to a second set time is possible with “immune” RNA, even when there is Ehrlich ascites tumour in the recipient animal1,2. McCarthy showed that the presence of Ehrlich ascites tumour in mice delays the rejection of skin allografts3, and Mannick and Egdahl transferred adoptive allograft immunity in rabbits by spleen cell RNA using in vitro incubation with lymphoid cells4. This experimental model of Ehrlich ascites tumour in White Swiss recipient animals has also been studied in this laboratory in relation to tumour growth resisting factors and host immune status5,6.
Similar content being viewed by others
References
Rigby, P. G., Clin. Res., 15, 339 (1967).
Rigby, P. G., J. Lab. Clin. Med., 71, 775 (1968).
McCarthy, R. F., Cancer Res., 24, 915 (1964).
Mannick, J. A., and Egdahl, R. H., J. Clin. Invest., 43, 2116 (1964).
Brenneman, M., and Rigby, P. G., Brit. J. Cancer, 22, 58 (1968).
Brenneman, M., and Rigby, P. G., Cancer Res., 28, 1138 (1968).
Alexander, P., Delorme, E. J., Hamilton, L. D. G., and Hall, J. G., Nature, 213, 569 (1967).
Pagano, J. S., Basic Tech. in Virol. (in the press).
Pagano, J. S., McCutchan, J. H., and Vaheri, A., J. Virol., 1, 891 (1967).
Vaheri, A., and Pagano, J. S., Virology, 27, 434 (1965).
Mach, B., and Vassalli, P., Proc. US. Nat. Acad. Sci., 54, 975 (1965).
Rigby, P. G., J. Lab. Clin. Med., 69, 800 (1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
RIGBY, P. Prolongation of Survival of Tumour-bearing Animals by Transfer of “Immune” RNA with DEAE Dextran. Nature 221, 968–969 (1969). https://doi.org/10.1038/221968a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/221968a0
- Springer Nature Limited
This article is cited by
-
Biopolymers and Osmolytes — A Focus towards the Prospects of Stability and Adjuvanticity of Vaccines
Macromolecular Research (2022)
-
Immunotherapy of human malignancies with immune RNA
World Journal of Surgery (1977)
-
Transfer of tumor specific immunity with ?immune? RNA: prospects for the treatment of human cancer
Klinische Wochenschrift (1976)